The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...
The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides interventional cardiologists, cardiothoracic surgeons, and heart teams with ...
WASHINGTON—The Society for Cardiovascular Angiography & Interventions (SCAI) has published an expert consensus statement that provides ...
The UHS Heart & Vascular Institute recently celebrated a significant milestone with the completion of their 1,000th TAVR (Transcatheter Aortic Valve Replacement) procedure. This achievement is ...
Executives expect a new label indication and a hoped-for easing of hospital capacity constraints to accelerate sales this ...
Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion, has ...
Discover how recent advancements in cardiovascular medicine, including TAVI and TEER, are revolutionizing heart disease ...
Zovighian said the transition to CEO has been relatively smooth since he joined Edwards in 2015 and spent eight years in ...
Minimally invasive heart procedures like transcatheter aortic valve replacement (TAVR) and MitraClip placement to treat mitral regurgitation can improve quality of life, and even be lifesaving, for ...
37,249 people played the daily Crossword recently. Can you solve it faster than others?37,249 people played the daily Crossword recently. Can you solve it faster than others? EXCLUSIVE: John Goodman ...
5d
Zacks.com on MSNShould Edwards Lifesciences Stock Remain in Your Portfolio Now?EW stock is on investors' radars due to the promising structural heart opportunities following the divestment of the Critical Care arm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results